ESH AL 2018 | Support systems are a crucial factor in ALL treatment

Wendy Stock

Acute lymphoblastic leukemia (ALL) treatment regimens are long and debilitating, which is especially hard on young adults who are already going through a transitional phase of their lives; this makes providing a support system even more crucial. Here, Wendy Stock, MD, from the University of Chicago Medical Centre, Chicago, IL, emphasizes the need to establish support networks for these patients. Dr Stock’s own clinic provides multidisciplinary, comprehensive care, thus reducing the need for patient trips to different locations. She highlights how this community has improved treatment compliance, even in adult patients, a topic that is far too often overlooked. This interview was recorded at the 2018 European School of Haematology (ESH) Clinical Updates on Acute Leukaemias, held in Budapest, Hungary.

Share this video